These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Replacement therapy of emphysema caused by alpha 1-antitrypsin deficiency].
    Author: Vidal R, Miravitlles M, de Gracia X, Gallego B, Morell F.
    Journal: Med Clin (Barc); 1991 Feb 09; 96(5):180-2. PubMed ID: 2033989.
    Abstract:
    The most common feature of alpha1-antitrypsin (alpha 1 AT) deficiency is pulmonary emphysema, which becomes manifest in the third to fifth life decades in most subjects with PiZZ phenotype. In recent years, replacement therapy with alpha 1 AT from the plasma of blood donors has been developed. We report the protocol of treatment which has begun to be used in our center, now including two patients. We discuss inclusion criteria, the treatment schedules, the adverse side-effects and the future outlook for this type of therapy.
    [Abstract] [Full Text] [Related] [New Search]